Zhong Lun advised Immorna advised in the deal. Immorna established a joint venture to collaborate globally on the development and commercialization of innovative drug programs in oncology,...
Immorna’s Joint Venture with Junshi Biosciences
Beisen’s $260 Million Series F Financing Round
Zhong Lun Law Firm advised SoftBank Vision Fund II on the deal. Beisen, a well-known Chinese integrated HR SaaS and talent management platform operator, executed the...